Home Newsfeeds Keybanc Maintains Overweight on Ventas, Lowers Price Target to $55

Keybanc Maintains Overweight on Ventas, Lowers Price Target to $55

Keybanc analyst Austin Wurschmidt maintains Ventas (NYSE:VTR) with a Overweight and lowers the price target from $56 to $55.

February 1, 2023

1 minute read

Keybanc analyst Austin Wurschmidt maintains Ventas (NYSE:VTR) with a Overweight and lowers the price target from $56 to $55.

Analyst Ratings for NXP Semiconductors

December 5, 1:00 PM

Analysts have provided the following ratings for NXP Semiconductors (NASDAQ:NXPI) within the last quarter: Bullish Somewhat Bullish Indifferent…

February 8, 2:25 PM

Kenvue's Q4 2023 sales update: $3.67 billion, down 2.7%. Discover organic growth, net sales, and projections for fiscal year 2024.

July 27, 11:13 AM

Shares of Lam Research Corporation (NASDAQ: LRCX) spiked in early trading on Thursday, after the company reported upbeat quarterly results.

February 24, 7:19 AM

HC Wainwright & Co. analyst Andrew Fein reiterates C4 Therapeutics (NASDAQ:CCCC) with a Buy and maintains $35 price target.